JP2014505014A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014505014A5 JP2014505014A5 JP2013536845A JP2013536845A JP2014505014A5 JP 2014505014 A5 JP2014505014 A5 JP 2014505014A5 JP 2013536845 A JP2013536845 A JP 2013536845A JP 2013536845 A JP2013536845 A JP 2013536845A JP 2014505014 A5 JP2014505014 A5 JP 2014505014A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- amino acids
- amino acid
- acid sequence
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40740210P | 2010-10-27 | 2010-10-27 | |
| US61/407,402 | 2010-10-27 | ||
| US201161467894P | 2011-03-25 | 2011-03-25 | |
| US61/467,894 | 2011-03-25 | ||
| US201161502476P | 2011-06-29 | 2011-06-29 | |
| US61/502,476 | 2011-06-29 | ||
| PCT/US2011/058165 WO2012058480A1 (en) | 2010-10-27 | 2011-10-27 | Fviii peptides for immune tolerance induction and immunodiagnostics |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016230723A Division JP2017095463A (ja) | 2010-10-27 | 2016-11-29 | 免疫寛容誘導および免疫診断のためのｆｖｉｉｉペプチド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014505014A JP2014505014A (ja) | 2014-02-27 |
| JP2014505014A5 true JP2014505014A5 (enExample) | 2014-12-11 |
| JP6122780B2 JP6122780B2 (ja) | 2017-04-26 |
Family
ID=45349271
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013536845A Expired - Fee Related JP6122780B2 (ja) | 2010-10-27 | 2011-10-27 | 免疫寛容誘導および免疫診断のためのｆｖｉｉｉペプチド |
| JP2016230723A Pending JP2017095463A (ja) | 2010-10-27 | 2016-11-29 | 免疫寛容誘導および免疫診断のためのｆｖｉｉｉペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016230723A Pending JP2017095463A (ja) | 2010-10-27 | 2016-11-29 | 免疫寛容誘導および免疫診断のためのｆｖｉｉｉペプチド |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US8969524B2 (enExample) |
| EP (2) | EP3260132B1 (enExample) |
| JP (2) | JP6122780B2 (enExample) |
| KR (2) | KR102040867B1 (enExample) |
| CN (2) | CN104926947A (enExample) |
| AR (1) | AR083586A1 (enExample) |
| AU (2) | AU2011319747C1 (enExample) |
| BR (1) | BR112013010362A2 (enExample) |
| CA (1) | CA2815239C (enExample) |
| DK (1) | DK2632479T3 (enExample) |
| EA (1) | EA034494B1 (enExample) |
| ES (2) | ES2639039T3 (enExample) |
| HK (1) | HK1215442A1 (enExample) |
| MX (1) | MX347805B (enExample) |
| NZ (2) | NZ703514A (enExample) |
| PL (2) | PL2632479T3 (enExample) |
| PT (1) | PT2632479T (enExample) |
| SG (2) | SG10201600656WA (enExample) |
| TW (3) | TW201708251A (enExample) |
| WO (1) | WO2012058480A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100256062A1 (en) | 2004-12-06 | 2010-10-07 | Howard Tommy E | Allelic Variants of Human Factor VIII |
| BR112015010625B1 (pt) * | 2012-11-12 | 2023-03-07 | Apitope International Nv | Peptídeos |
| WO2014089541A2 (en) | 2012-12-07 | 2014-06-12 | Haplomics, Inc. | Factor viii mutation repair and tolerance induction |
| WO2014145524A2 (en) * | 2013-03-15 | 2014-09-18 | Haplomics, Inc. | Compositions and methods for immune tolerance induction to factor viii replacement therapies in subjects with hemophilia a |
| JP6488376B2 (ja) * | 2014-06-12 | 2019-03-20 | ユニヴァーシティ オブ ハワイＵｎｉｖｅｒｓｉｔｙ Ｏｆ Ｈａｗａｉｉ | 免疫原性を低減するかまたは予防するためのヒト化コブラ毒因子を含む医薬組成物、薬剤および組み合わせ医薬 |
| US20180002435A1 (en) * | 2015-01-26 | 2018-01-04 | Cellectis | mAb-DRIVEN CHIMERIC ANTIGEN RECEPTOR SYSTEMS FOR SORTING/DEPLETING ENGINEERED IMMUNE CELLS |
| MY197302A (en) | 2016-04-15 | 2023-06-12 | Takeda Pharmaceuticals Co | Method and apparatus for providing a pharmacokinetic drug dosing regimen |
| US10896749B2 (en) | 2017-01-27 | 2021-01-19 | Shire Human Genetic Therapies, Inc. | Drug monitoring tool |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003087161A1 (en) | 2002-04-18 | 2003-10-23 | Merck Patent Gmbh | Modified factor viii |
| US7485314B2 (en) * | 2002-05-06 | 2009-02-03 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Induction of antigen specific immunologic tolerance |
| DE602005013670D1 (de) * | 2004-05-21 | 2009-05-14 | Inst Systems Biology | Zusammensetzungen und verfahren zur quantifizierung von serumglykoproteinen |
| US20060094104A1 (en) | 2004-10-29 | 2006-05-04 | Leopold Grillberger | Animal protein-free media for cultivation of cells |
| CA2633306A1 (en) | 2006-01-04 | 2007-07-12 | Baxter International Inc. | Oligopeptide-free cell culture media |
| GB0723712D0 (en) | 2007-12-04 | 2008-01-16 | Apitope Technology Bristol Ltd | Peptides |
| US7673687B2 (en) | 2007-12-05 | 2010-03-09 | Halliburton Energy Services, Inc. | Cement compositions comprising crystalline organic materials and methods of using same |
| DE202007017320U1 (de) | 2007-12-07 | 2008-02-28 | Dittmann, Ludwig | Vorrichtung zur Raumbeduftung |
| GB0801513D0 (en) * | 2008-01-28 | 2008-03-05 | Circassia Ltd | Peptides from factor VIII |
| US20110081362A1 (en) | 2008-01-31 | 2011-04-07 | The Brigham And Women's Hospital, Inc. | Treatment of cancer |
| BRPI0921429B1 (pt) | 2008-11-07 | 2022-07-12 | Takeda Pharmaceutical Company Limited | Formulação farmacêutica liofilizada estável, e, método para preparar um fator liofilizado estável |
-
2011
- 2011-10-27 CN CN201510431485.4A patent/CN104926947A/zh active Pending
- 2011-10-27 PT PT117968461T patent/PT2632479T/pt unknown
- 2011-10-27 MX MX2013004753A patent/MX347805B/es active IP Right Grant
- 2011-10-27 CA CA2815239A patent/CA2815239C/en active Active
- 2011-10-27 JP JP2013536845A patent/JP6122780B2/ja not_active Expired - Fee Related
- 2011-10-27 ES ES11796846.1T patent/ES2639039T3/es active Active
- 2011-10-27 NZ NZ703514A patent/NZ703514A/en unknown
- 2011-10-27 SG SG10201600656WA patent/SG10201600656WA/en unknown
- 2011-10-27 DK DK11796846.1T patent/DK2632479T3/en active
- 2011-10-27 CN CN201180063117.9A patent/CN103298482B/zh active Active
- 2011-10-27 TW TW105138248A patent/TW201708251A/zh unknown
- 2011-10-27 KR KR1020137013231A patent/KR102040867B1/ko active Active
- 2011-10-27 WO PCT/US2011/058165 patent/WO2012058480A1/en not_active Ceased
- 2011-10-27 TW TW106113613A patent/TW201730205A/zh unknown
- 2011-10-27 PL PL11796846T patent/PL2632479T3/pl unknown
- 2011-10-27 EP EP17167928.5A patent/EP3260132B1/en active Active
- 2011-10-27 US US13/283,452 patent/US8969524B2/en active Active
- 2011-10-27 SG SG2013028733A patent/SG189914A1/en unknown
- 2011-10-27 AU AU2011319747A patent/AU2011319747C1/en active Active
- 2011-10-27 BR BR112013010362A patent/BR112013010362A2/pt not_active Application Discontinuation
- 2011-10-27 EA EA201390617A patent/EA034494B1/ru not_active IP Right Cessation
- 2011-10-27 KR KR1020197032106A patent/KR102222864B1/ko not_active Expired - Fee Related
- 2011-10-27 EP EP11796846.1A patent/EP2632479B1/en active Active
- 2011-10-27 TW TW100139078A patent/TWI580430B/zh not_active IP Right Cessation
- 2011-10-27 ES ES17167928T patent/ES2912455T3/es active Active
- 2011-10-27 NZ NZ609474A patent/NZ609474A/en unknown
- 2011-10-27 PL PL17167928.5T patent/PL3260132T3/pl unknown
- 2011-10-28 AR ARP110103988A patent/AR083586A1/es not_active Application Discontinuation
-
2015
- 2015-01-23 US US14/604,622 patent/US9512198B2/en active Active
-
2016
- 2016-03-22 HK HK16103339.6A patent/HK1215442A1/zh unknown
- 2016-04-06 AU AU2016202155A patent/AU2016202155B2/en active Active
- 2016-11-02 US US15/341,936 patent/US20170267743A1/en not_active Abandoned
- 2016-11-29 JP JP2016230723A patent/JP2017095463A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014505014A5 (enExample) | ||
| TWI880898B (zh) | 單鏈嵌合多肽及其用途 | |
| Botos et al. | The structural biology of Toll-like receptors | |
| CN110612446B (zh) | 分离新抗原-特异性t细胞受体序列的方法 | |
| JP2013529070A5 (enExample) | ||
| Church | Clinical advances in therapies targeting the interleukin‐2 receptor | |
| JP2017160222A5 (enExample) | ||
| JP2017529067A5 (enExample) | ||
| JP2017018125A5 (enExample) | ||
| JP2016052315A5 (enExample) | ||
| JP2016508143A5 (enExample) | ||
| JP2015134758A5 (enExample) | ||
| JP2013525305A5 (enExample) | ||
| JP2013513377A5 (enExample) | ||
| JP2013521789A5 (enExample) | ||
| JP2013517783A5 (enExample) | ||
| JP2010533200A5 (enExample) | ||
| JP2012529296A5 (enExample) | ||
| JP2014521313A5 (enExample) | ||
| JP2015514132A5 (enExample) | ||
| JP2019520038A5 (enExample) | ||
| JP2005523681A5 (enExample) | ||
| JP2015524788A5 (enExample) | ||
| US20230197192A1 (en) | Selecting neoantigens for personalized cancer vaccine | |
| JP2015529629A5 (enExample) |